Skip to main content
OpenTrials
Completed

NCT Number: NCT02323347

Cut-Off Progesterone Values Deleterious for In Vitro Fertilization and Fresh Embryo Transfer

At which deleterious cut off value of progesterone on day of HCG (P-hCG) in our IVF program should fresh embryo transfer (ET) be cancelled?

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Progesterone Fertilization in Vitro Genital Diseases Infertility Pregnancy Urogenital Diseases

Age range

18 year–49 year

Sex eligibility

Female

Study type

Observational

About this study

There is still an ongoing debate on the effect of subtle increased P-hCG concentration on pregnancy outcome after fresh ET. No consensus on the cut-off value to define increased P-hCG seems to exist. It is accepted that high P advances endometrium, leading to asynchrony between the implanting embryo and the endometrium, and resulting in implantation failure. A freeze all embryos policy and postponement of ET in subsequent frozen-thawed cycle has been proposed.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Fresh embryo transfer
  • Progesterone value on day HCG (Human choriogonadotrophin hormone)

Exclusion criteria

  • Clinical indication for delaying embryo transfer

Treatment and study plan

Progesterone

Other

Progesterone level

Primary outcomes

  1. Clinical Pregnancy

    Time frame: 6 weeks after embryo transfer procedure

Sponsors and collaborators

Lead sponsor

Fundacion Dexeus

Other

Registry information

Important dates

Study start
2009
Primary completion
2014
Study completion
2014
First posted
Dec 23, 2014
Registry last updated
Dec 23, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.